All Stories

  1. Differential Effects of Repetitive Transcranial Magnetic Stimulation on Mood and Pain Symptoms in People With Chronic Pain and Major Depressive Disorders—A Review
  2. Ketamine versus electroconvulsive therapy for major depressive episode: An updated systematic review and non-inferiority meta-analysis
  3. Erupted compound odontoma in patient with epileptic seizures - a case report
  4. A study protocol for an ongoing multi-arm, randomized, double-blind, sham-controlled clinical trial with digital features, using portable transcranial electrical stimulation and internet-based behavioral therapy for major depression disorders: The PSYL...
  5. Interventional psychiatry: 13 reasons why
  6. Interventional Psychiatry: 13 reasons why
  7. Cognitive outcomes after tDCS in schizophrenia patients with prominent negative symptoms: Results from the placebo-controlled STARTS trial
  8. Adjunctive Therapy to Manage Neuropsychiatric Symptoms in Moderate and Severe Dementia: Randomized Clinical Trial Using an Outpatient Version of Tailored Activity Program
  9. Repetitive Transcranial Magnetic Stimulation for Major Depressive Disorder in Older Adults: Systematic Review and Meta-analysis
  10. Effects of transcranial direct current stimulation (tDCS) and concurrent cognitive training on episodic memory in patients with traumatic brain injury: a double-blind, randomised, placebo-controlled study
  11. Treatment of mixed depression with theta-burst stimulation (TBS): results from a double-blind, randomized, sham-controlled clinical trial
  12. Prevalence and risk factors of psychiatric symptoms and diagnoses before and during the COVID-19 pandemic: findings from the ELSA-Brasil COVID-19 mental health cohort
  13. Transcranial direct current stimulation (tDCS) in the management of epilepsy: A systematic review
  14. Transkranielle elektrische Hirnstimulationsverfahren zur Behandlung der Negativsymptomatik bei Schizophrenie
  15. Schizophrenia: Negative Symptoms
  16. Medical cannabinoids for treatment of neuropsychiatric symptoms in dementia: a systematic review
  17. Gamma transcranial alternating current stimulation for treatment of negative symptoms in schizophrenia: Report of two cases
  18. Mental Health Status of Psychogeriatric Patients During the 2019 New Coronavirus Disease (COVID-19) Pandemic and Effects on Caregiver Burden
  19. Immunization stress-related responses presenting as psychogenic non-epileptic seizures following HPV vaccination in Rio Branco, Brazil
  20. Gamma transcranial alternating current stimulation in patients with negative symptoms in schizophrenia: A case series
  21. Early diagnosis and treatment of Alzheimer’s disease: new definitions and challenges
  22. Precision non-implantable neuromodulation therapies: a perspective for the depressed brain
  23. Efficacy, Safety, and Tolerability of Theta-Burst Stimulation in Mixed Depression: Design, Rationale, and Objectives of a Randomized, Double-Blinded, Sham-Controlled Trial
  24. Efficacy and Safety of Transcranial Direct Current Stimulation for Treating Negative Symptoms in Schizophrenia
  25. Schizophrenia TreAtment with electRic Transcranial Stimulation (STARTS): design, rationale and objectives of a randomized, double-blinded, sham-controlled trial
  26. Changes in motor cortical excitability in schizophrenia following transcranial direct current stimulation
  27. Cognitive outcomes of TMS treatment in bipolar depression: Safety data from a randomized controlled trial
  28. Frailty in older adults with amnestic mild cognitive impairment as a result of Alzheimer's disease: A comparison of two models of frailty characterization
  29. Treatment of Bipolar Depression with Deep TMS: Results from a Double-Blind, Randomized, Parallel Group, Sham-Controlled Clinical Trial
  30. Transcranial direct current stimulation for the treatment of post-stroke depression: results from a randomised, sham-controlled, double-blinded trial
  31. Home-Based Psychiatric Outpatient Care Through Videoconferencing for Depression: A Randomized Controlled Follow-Up Trial
  32. Mood disorders in the elderly: prevalence, functional impact, and management challenges
  33. Antidepressant Efficacy of Adjunctive Aerobic Activity and Associated Biomarkers in Major Depression: A 4-Week, Randomized, Single-Blind, Controlled Clinical Trial
  34. Transcranial direct current stimulation for the treatment of post-stroke depression in aphasic patients: a case series
  35. Emotional reactivity to valence-loaded stimuli are related to treatment response of neurocognitive therapy
  36. Plasma levels of soluble TNF receptors 1 and 2 after tDCS and sertraline treatment in major depression: Results from the SELECT-TDCS trial
  37. Epistasis between COMT Val158Met and DRD3 Ser9Gly polymorphisms and cognitive function in schizophrenia: genetic influence on dopamine transmission
  38. Decreased AKT1/mTOR pathway mRNA expression in short-term bipolar disorder
  39. Role of quetiapine beyond its clinical efficacy in bipolar disorder: From neuroprotection to the treatment of psychiatric disorders (Review)
  40. Transcranial direct current stimulation in psychiatric disorders
  41. Assessment of non-BDNF neurotrophins and GDNF levels after depression treatment with sertraline and transcranial direct current stimulation in a factorial, randomized, sham-controlled trial (SELECT-TDCS): An exploratory analysis
  42. Comorbid epilepsy and psychogenic non-epileptic seizures: How well do patients and caregivers distinguish between the two
  43. BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: Results from a factorial, randomized, sham-controlled trial
  44. Cognitive control therapy and transcranial direct current stimulation for depression: A randomized, double-blinded, controlled trial
  45. Enhancement of Affective Processing Induced by Bifrontal Transcranial Direct Current Stimulation in Patients With Major Depression
  46. Impact of 5-HTTLPR and BDNF polymorphisms on response to sertraline versus transcranial direct current stimulation: Implications for the serotonergic system
  47. Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial
  48. Transcranial direct current stimulation and repetitive transcranial magnetic stimulation in consultation-liaison psychiatry
  49. Bifrontal tDCS prevents implicit learning acquisition in antidepressant-free patients with major depressive disorder
  50. THE SERTRALINE VERSUS ELECTRICAL CURRENT THERAPY FOR TREATING DEPRESSION CLINICAL STUDY (SELECT-TDCS): RESULTS OF THE CROSSOVER AND FOLLOW-UP PHASES
  51. The Sertraline vs Electrical Current Therapy for Treating Depression Clinical Study
  52. Acute working memory improvement after tDCS in antidepressant-free patients with major depressive disorder
  53. Formal Thought Disorder and language impairment in schizophrenia
  54. Plasma cortisol in first episode drug-naïve mania: Differential levels in euphoric versus irritable mood
  55. A systematic review and meta‐analysis of heart rate variability in epilepsy and antiepileptic drugs
  56. Manic Psychosis After Sertraline and Transcranial Direct-Current Stimulation
  57. Sertraline vs. ELectrical Current Therapy for Treating Depression Clinical Trial - SELECT TDCS: Design, rationale and objectives
  58. Intracranial arterial aneurysms in childhood: case report
  59. Genetic therapy in gliomas: Historical analysis and future perspectives